Rising incidence of cancer, infectious diseases, and genetic disorders; growth in funding for research on genomic, proteomic, and electrophoresis techniques; growing number of industry-academia research collaborations; growing use of capillary electrophoresis with mass spectroscopy; and growth in the number of clinical, forensic, and research laboratories are the major factors driving the growth of the electrophoresis market during the forecast period.
The global Electrophoresis market size is projected to reach USD 2.80 Billion by 2022 from an estimated USD 2.15 Billion in 2017, at a CAGR of 5.4%.
Bio-Rad Laboratories (U.S.), GE Healthcare (U.S.), Thermo Fisher Scientific Inc. (U.S.), Danaher Corporation (U.S.), Agilent Technologies (U.S.), Merck Millipore (U.S.), PerkinElmer, Inc. (U.S.), QIAGEN N.V. (Netherlands), Lonza Group Ltd. (Switzerland), Shimadzu Corporation (Japan), Harvard Bioscience, Inc. (U.S.), Sebia Group (U.K.), and C.B.S. Scientific Company, Inc. (U.S.) are some key players in this market. These companies are focusing on increasing their presence in the high-growth markets through both organic as well as inorganic growth strategies such as product launches, acquisitions, and expansions.
For More Details, Download a PDF Brochure:-
“Bio-Rad Laboratories (U.S.) dominated the global electrophoresis market in 2016”
The company offers a wide range of products in the electrophoresis market, which includes nucleic electrophoresis & blotting, protein electrophoresis & blotting, power supplies, automated electrophoresis systems, gel documentation systems, and gel imaging systems. The company is focusing on product developments with upgraded technology to meet the demand of the electrophoresis market. In May 2017, the company launched its ChemiDoc MP Digital Imaging System—a gel documentation product. The company also focuses on acquiring local and international players providing life science products to expand its business.
“GE Healthcare (U.S.) develops transformational outcome-based solutions through a combination of leading medical technologies, services, and digital platforms”
Major electrophoresis products provided by GE Healthcare are for protein research, DNA & RNA research, and drug discovery & development. The company provides a wide range of electrophoresis equipment including vertical & horizontal electrophoresis systems, automated electrophoresis systems, reagents, and capillary electrophoresis systems. The company is growing its presence in many geographies by acquiring local players that will aid its core segments. In 2017, GE Healthcare acquired Zenith Technologies (Ireland), a technology company delivering and manufacturing software systems and solutions for the life sciences industry.
We can help with your specific research requirement for this market. Please share your specific interest to help us serve you better, Request Sample Pages:-